• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KDIGO 临床实践指南:肾移植候选人的评估和管理。

KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.

机构信息

Royal Prince Alfred Hospital and Charles Perkins Centre, University of Sydney, Sydney, Australia.

Seoul National University, Seoul, South Korea.

出版信息

Transplantation. 2020 Apr;104(4S1 Suppl 1):S11-S103. doi: 10.1097/TP.0000000000003136.

DOI:10.1097/TP.0000000000003136
PMID:32301874
Abstract

The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is intended to assist health care professionals worldwide who evaluate and manage potential candidates for deceased or living donor kidney transplantation. This guideline addresses general candidacy issues such as access to transplantation, patient demographic and health status factors, and immunological and psychosocial assessment. The roles of various risk factors and comorbid conditions governing an individual's suitability for transplantation such as adherence, tobacco use, diabetes, obesity, perioperative issues, causes of kidney failure, infections, malignancy, pulmonary disease, cardiac and peripheral arterial disease, neurologic disease, gastrointestinal and liver disease, hematologic disease, and bone and mineral disorder are also addressed. This guideline provides recommendations for evaluation of individual aspects of a candidate's profile such that each risk factor and comorbidity are considered separately. The goal is to assist the clinical team to assimilate all data relevant to an individual, consider this within their local health context, and make an overall judgment on candidacy for transplantation. The guideline development process followed the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) approach. Guideline recommendations are primarily based on systematic reviews of relevant studies and our assessment of the quality of that evidence, and the strengths of recommendations are provided. Limitations of the evidence are discussed with differences from previous guidelines noted and suggestions for future research are also provided.

摘要

2020 年肾脏病:改善全球预后(KDIGO)关于评估和管理肾移植候选人的临床实践指南旨在协助全球评估和管理已故或活体供肾移植潜在候选人的医疗保健专业人员。本指南涉及一般候选资格问题,如获得移植的机会、患者人口统计学和健康状况因素以及免疫和社会心理评估。还涉及各种风险因素和合并症对个体移植适宜性的影响,例如依从性、吸烟、糖尿病、肥胖、围手术期问题、肾衰竭原因、感染、恶性肿瘤、肺部疾病、心脏和外周动脉疾病、神经疾病、胃肠道和肝脏疾病、血液疾病以及骨骼和矿物质疾病。本指南提供了评估候选人个人资料各个方面的建议,以便分别考虑每个风险因素和合并症。目标是帮助临床团队整合与个体相关的所有数据,在当地卫生环境下考虑这些数据,并对移植候选资格做出总体判断。指南制定过程遵循推荐评估、制定和评估(GRADE)方法。指南建议主要基于对相关研究的系统评价以及我们对该证据质量的评估,同时提供了建议的强度。讨论了证据的局限性,并指出了与以前指南的差异,还提供了未来研究的建议。

相似文献

1
KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.KDIGO 临床实践指南:肾移植候选人的评估和管理。
Transplantation. 2020 Apr;104(4S1 Suppl 1):S11-S103. doi: 10.1097/TP.0000000000003136.
2
Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.KDIGO 临床实践指南:评估和管理肾移植候选人。
Transplantation. 2020 Apr;104(4):708-714. doi: 10.1097/TP.0000000000003137.
3
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.KDIGO 活体肾捐献者评估与管理临床实践指南
Transplantation. 2017 Aug;101(8S Suppl 1):S1-S109. doi: 10.1097/TP.0000000000001769.
4
Use of a new end-stage kidney disease risk calculator in the Kidney Disease Improving Global Outcomes guideline to evaluate the impact of different living kidney donor candidate assessments.在改善全球肾脏病预后组织指南中使用一种新的终末期肾病风险计算器,以评估不同活体肾供体候选者评估的影响。
Nephrology (Carlton). 2018 Jul;23(7):616-624. doi: 10.1111/nep.13074.
5
Preface.前言。
Transplantation. 2020 Apr;104(4S1 Suppl 1):S4-S5. doi: 10.1097/01.tp.0000660596.72821.78.
6
Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice.2017KDIGO 指南在活体肾供者评估和照护中的应用。
Clin J Am Soc Nephrol. 2020 Jun 8;15(6):896-905. doi: 10.2215/CJN.12141019. Epub 2020 Apr 10.
7
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.KDIGO 临床实践指南:肾移植受者的护理概述。
Kidney Int. 2010 Feb;77(4):299-311. doi: 10.1038/ki.2009.377. Epub 2009 Oct 21.
8
KDOQI US Commentary on the 2020 KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation.KDIGO 美国评论:2020 年 KDIGO 临床实践指南:肾脏移植候选人的评估和管理。
Am J Kidney Dis. 2021 Jun;77(6):833-856. doi: 10.1053/j.ajkd.2020.11.017. Epub 2021 Mar 18.
9
KDIGO clinical practice guideline for the care of kidney transplant recipients.KDIGO 临床实践指南:肾移植受者的护理。
Am J Transplant. 2009 Nov;9 Suppl 3:S1-155. doi: 10.1111/j.1600-6143.2009.02834.x.
10
European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care.欧洲肾脏最佳实践指南:肾脏供体与受体评估及围手术期护理
Nephrol Dial Transplant. 2015 Nov;30(11):1790-7. doi: 10.1093/ndt/gfu216. Epub 2014 Jul 9.

引用本文的文献

1
Malignancy in Dialysis Patients-How Serious Is the Problem, Especially in Relation to Waiting List Status?透析患者的恶性肿瘤——问题有多严重,尤其是与等待名单状态相关的情况?
Cancers (Basel). 2025 Aug 26;17(17):2782. doi: 10.3390/cancers17172782.
2
A Machine Learning-Based Model to Estimate the Risk of Pulmonary Hypertension in Chronic Kidney Disease Patients.一种基于机器学习的模型,用于评估慢性肾脏病患者发生肺动脉高压的风险。
J Clin Hypertens (Greenwich). 2025 Sep;27(9):e70132. doi: 10.1111/jch.70132.
3
The predictive value of tacrolimus intrapatient variability and time in therapeutic range for renal transplant outcomes.
他克莫司患者内变异性及治疗范围内时间对肾移植结局的预测价值。
Ren Fail. 2025 Dec;47(1):2549395. doi: 10.1080/0886022X.2025.2549395. Epub 2025 Sep 3.
4
Unusual Late Onset Recurrent Venous Thrombosis in Two Young Post Renal Transplant Recipients - Challenges in Diagnosis and Management with Review of Literature.两名年轻肾移植受者罕见的迟发性复发性静脉血栓形成——诊断和管理挑战及文献综述
Indian J Nephrol. 2025 Jul-Aug;35(4):564-568. doi: 10.25259/IJN_207_2024. Epub 2024 Jul 15.
5
Continuous Glucose Monitoring in a Renal Transplant Setting.肾移植环境中的连续血糖监测
Indian J Nephrol. 2025 Jul-Aug;35(4):582-583. doi: 10.25259/IJN_732_2024. Epub 2025 Mar 6.
6
Major adverse cardiovascular events and hyperuricemia as an effect-modifying factor in kidney transplant recipients.主要不良心血管事件及高尿酸血症作为肾移植受者的效应修饰因素
World J Transplant. 2025 Sep 18;15(3):102287. doi: 10.5500/wjt.v15.i3.102287.
7
Deceased donor kidney transplantation in candidates with pre-transplant hematological malignancies: a literature review and recipient allocation proposal in Singapore.移植前存在血液系统恶性肿瘤的候选者接受 deceased donor 肾脏移植:新加坡的文献综述及受者分配建议
J Nephrol. 2025 Aug 22. doi: 10.1007/s40620-025-02381-8.
8
Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes.肾移植受者既往的肿瘤血液学疾病:对移植肾存活、急性排斥反应及长期临床结局的影响
Front Immunol. 2025 Aug 6;16:1629521. doi: 10.3389/fimmu.2025.1629521. eCollection 2025.
9
A randomized, controlled, 12-month trial on the effects of an interdisciplinary treatment approach in ESRD patients: study protocol of the smart and fit for kidney transplantation trial (S&F4KTx).一项关于跨学科治疗方法对终末期肾病患者影响的随机对照12个月试验:适合肾移植的智能与健康试验(S&F4KTx)的研究方案。
Trials. 2025 Aug 21;26(1):298. doi: 10.1186/s13063-025-09022-2.
10
Prospective evaluation of arterial spin labeling and diffusion tensor imaging-magnetic resonance imaging for the non-invasive assessment of renal allograft dysfunction.动脉自旋标记和扩散张量成像磁共振成像对肾移植功能障碍进行无创评估的前瞻性研究
Quant Imaging Med Surg. 2025 Aug 1;15(8):6882-6896. doi: 10.21037/qims-2025-604. Epub 2025 Jul 29.